Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KB2 | Q9UBS0 | 2/20 | 0.60 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.57 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.50 |
| ▸ | ME2 | P23368 | 1/20 | 0.48 |
| ▸ | ME1 | P48163 | 1/20 | 0.48 |
| ▸ | ME3 | Q16798 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.48 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17203114 | 0.90 | TRPV1 (0.66) | RPS6KB2TRPV1CYP2E1CYP3A4CYP2A6 | |
| SCHEMBL3169908 | 0.85 | RPS6KB2 (0.49) | RPS6KB2TRPV1CYP2C9CYP2C19FFAR1 | |
| SCHEMBL14340893 | 0.82 | RPS6KB2 (0.64) | RPS6KB2TRPV1CYP2E1CYP3A4CYP2A6 | |
| SCHEMBL21067539 | 0.82 | ACKR3 (0.49) | RPS6KB2TRPV1FFAR1POLBALDH1A1 | |
| SCHEMBL5663464 | 0.81 | ACACA (0.60) | RPS6KB2TRPV1CYP2E1CYP3A4CYP2A6 | |
| SCHEMBL8607007 | 0.81 | TRPV1 (0.64) | RPS6KB2TRPV1CYP2E1CYP3A4CYP2A6 | |
| SCHEMBL9169334 | 0.80 | RPS6KB2 (0.51) | RPS6KB2FFAR1HDAC1HDAC3HDAC2 | |
| SCHEMBL11624972 | 0.79 | CYP2A6 (0.60) | TRPV1CYP2E1CYP3A4CYP2A6CYP2C9 | |
| SCHEMBL5664372 | 0.79 | RPS6KB2 (0.57) | RPS6KB2FFAR1HDAC1HDAC3HDAC2 | |
| SCHEMBL3173556 | 0.79 | RPS6KB2 (0.53) | RPS6KB2FFAR1ALDH1A1MEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1888566-A1 | 2-[(ISOQUINOLIN-3-CARBONYL)AMINO]-PROPIONIC ACID DERIVATIVES AS INHIBITORS OF FACTORS XI AND IX FOR THE TREATMENT OF THROMBOSIS | Transtech Pharma, Inc. (US) | 2008-02-20 | — | — | EP | disclosed |
| US-20070281969-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | MERCK SHARP & DOHME CORP. | 2007-12-06 | — | — | US | disclosed |
| WO-2006093823-A1 | 2- [ ISOQUINOLIN-S - CARBONYL ) AMINO] -PROPIONIC ACID DERIVATIVES AS INHIBITORS OF FACTORS XI AND IX FOR THE TREATMENT OF THROMBOSIS | TRANSTECH PHARMA, INC. (US) | 2006-09-08 | — | — | WO | disclosed |
| US-6939861-B2 | Amido macrolides | KOSAN BIOSCIENCES, INC. (US) | 2005-09-06 | — | — | US | disclosed |
| US-20030199458-A1 | Amido macrolides | KOSAN BIOSCIENCES, INC. | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281969-A1 | Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment | GPR119, FFAR1, HCAR1 | RPS6KB2 3986/4885TRPV1 275/4885CYP2E1 1129/4885 |
| US-20030199458-A1 | Amido macrolides | PCSK9, ABCB4, PCSK7 | RPS6KB2 400/4885TRPV1 2057/4885CYP2E1 1891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.